Risto Kaaja
Turku University Hospital
199 Papers
1.7K Citations
Risto Kaaja is an academic researcher from Turku University Hospital. The author has contributed to research in topics: Pregnancy & Medicine. The author has an hindex of 49, co-authored 194 publications. Previous affiliations of Risto Kaaja include University of Helsinki & Helsinki University Central Hospital.
Chat about Author
Papers
Comparison of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin, with or without dihydroergotamine, in abdominal hysterectomy.
Risto Kaaja,Pentti Lehtovirta,Pekka Venesmaa,Pauli Kajanoja,Pekka Halonen,Martti Gummerus,Seija Partanen +6 more
TL;DR: Enoxaparin caused less major bleeding than unfractionated heparin with or without dihydroergotamine in patients undergoing hysterectomy.
Clinical cure of severe, early onset preeclampsia with low molecular weight heparin therapy in primigravida with hyperreactio luteinalis and thrombophilia
TL;DR: A case of spontaneous hyperreactio luteinalis, where the clinical characteristics of PE improved after beginning LMWH therapy in severe, very early onset PE.
Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin.
TL;DR: Dalteparin is recommended instead of UF heparin for long-term thromboprophylaxis during and after pregnancy and puerperium for pregnant women with confirmed previous or current thromboembolism.
Pulse Wave Reflection in Currently and Previously Preeclamptic Women
TL;DR: It is demonstrated that pulse wave reflection and, thus, systemic arterial stiffness are increased in pregnant women with preeclampsia, but not in normotensive nonpregnant women with a history of preeClampsia.
Fetal Outcome in Lupus Pregnancy: A Retrospective Case-Control Study of 242 Pregnancies in 112 Patients:
Heikki Julkunen,T. Jouhikainen,Risto Kaaja,Marjatta Leirisalo-Repo,Eija Stephansson,Timo Palosuop,Kari Teramo,C. Friman +7 more
TL;DR: Fetal loss in SLE is 2.5 times more prevalent than in the normal population and the presence of lupus anticoagulant indicates a high risk for fetal loss, and the absence of aPL is an indication of a favorable pregnancy outcome.